Latest Breaking News On - Kahana investor relations - Page 1 : comparemela.com

/PRNewswire/ NeoTX announced today the acquisition of InterX. InterX, is a drug discovery company utilizing advanced proprietary tools of biomolecular.

United statesMichael levittRobert harowPrnewswire neoAsher nathanNeotx holdings ltdNobel prize laureate prof michael levittNobel laureatesComputer assisted drug discoveryNobel prize laureateRoger kornbergChief scientistTumor targeted superantigenNobel prize winningKahana investor relations